An Australian company that clinched the first US clearance for its at-home Covid-19 test kit has collapsed into liquidation after a sale to a competitor fell through. Covid-19 test maker Ellume Ltd.’s ...

Lucira Health Inc., a publicly traded maker of at-home Covid-19 testing kits, has filed for bankruptcy, saying an easing of pandemic restrictions has lowered demand for its products. Lucira, which ...

Cue Health, a San Diego biotech that ascended during the pandemic through mega funding and partnerships for its rapid COVID-19 test, said Wednesday that it is laying off half of its workforce as it ...

Aug 13 (Reuters) - Grail Inc (GRAL.O), opens new tab said on Tuesday it has cut about 350 existing jobs as the diagnostics company focuses on the development of its flagship cancer-detection test ...

Makers of COVID-19 testing tools are raking in billions while many consumers pay through the nose to find out if they are infected. Over-the-counter rapid tests have been pricey since they first ...

Gene-sequencing company Illumina ILMN2.06%increase; green up pointing triangle said Sunday it will divest itself of cancer blood test maker Grail, following Illumina’s loss in its legal battle against ...

Feb 13 (Reuters) - Softbank-backed (9434.T), opens new tab genetic test maker Invitae (NVTA.PK), opens new tab said on Tuesday it has filed for voluntary Chapter 11 protection in a U.S. bankruptcy ...

(CNN) — A new blood test can be performed in a pregnant person’s first trimester to help assess their risk of developing preeclampsia, a potentially life-threatening pregnancy complication. It’s the ...